Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC8H11FN4O3S |
InChIKeyVFMQZGNBWJRHOO-JGWLITMVSA-N |
CAS Registry2414069-54-6 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Preclinical | United States | 02 Apr 2021 |





